◆ 会议时间:2025年5月22-24日
◆ 会议地点:捷克, 布拉格
◆ 会议简介:
2025年第20届欧洲皮肤病与性病学会(EADV)春季研讨会将于2025年5月22-24日在捷克布拉格举行,预计有超过1500名代表出席会议。
欧洲皮肤病与性病学会(EADV)是成立于1987年的一个非营利医学学会,致力于推进皮肤性病学领域的教育、研究与培训的发展。EADV的愿景是成为欧洲首屈一指的皮肤性病学会,其首要目标是改善和提高对患者的护理,为欧洲所有的皮肤性病学家宣提供相关的继续医学教育等。EADV每年在欧洲国家举办一次代表大会和一次春季会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
European Academy of Dermatology and Venereology (EADV) Spring Symposium 2025
Dates: 22-24 May 2025
Venue: Prague, Czech Republic
以下为上届信息
摘要征文投稿:
- Abstracts submission opens: 19 Dec 2023
- Abstracts submission closes: 13 Feb 2024
- Abstracts evaluation notification :3 Apr 2024
点此提交摘要>>>Submit Abstract>>>
Preparation of your abstract
- Abstracts must be submitted in English. A “blind” selection process will be used.
- No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. Their names and affiliations (institutions) will be registered separately when submitting the abstract online.
- The title should not be written entirely in capital letters.
- The size of the abstract is limited to 3,000 characters.
- The submission program will automatically calculate the size of your abstract and will not allow submissions that do not fit in the size requirements.
- Tables and figures (graphs) are allowed and they are not taken into consideration for the character count. On the other hand, pictures of patients and body parts are NOT allowed. Abstract containing pictures will be rejected.
- In order to be able to submit your abstract you must use the template downloadable on the submission platform.
- Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted.
- Use generic names. The use of commercial drug names, brands and registered trademarks are strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation.
- No mention of pharmaceutical company names should be included in the abstract.
The authors should specify if they prefer their submission to be considered for:
- e-Poster presentation only
- Oral presentation only
If you submit your abstract as “Oral presentation” and it does not get selected for one of the Free Communication sessions, you will still have the possibility to submit an e-poster (if the abstract is considered above the threshold of acceptance by the reviewers).
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|